FDA Investigator Upendra Paudel
Upendra Paudel has conducted inspections on 36 sites in 1 countries as of 29 Mar 2022. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
36
Last Inspection Date:
29 Mar 2022
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Upendra Paudel:
Addie V Scott Boston,
Adriana N Jimenez Lopez,
Amanda B Athey,
Amber G Chung,
Andrea L Williams Jones,
Andrew J Howard,
Angela L Hatzenbuhler,
Ashley M Whitehurst,
Austin B Appler,
Brandon L Mariner,
Brian R Yaun,
Charlean R Butler,
Charles E Idjagboro,
Christopher L Taste,
Clarice J Ahn,
Collins M Mason,
David A Gonzalez,
David P Rice, Jr,
Deborah G Haney Cozzone,
Deshonna L Mitchell,
Donald R Hawn,
Dung N Tran,
Edette J Newby,
Edward P Potter,
Elaine G Stewart,
Elvis D Morton,
Emmanuel A Dimaano, Jr,
Esaw,
Gale L Glinecki,
Gerald W Kopp,
Heath R Harley,
Holly S Simms,
Iqra Iftikhar,
Isabel Y Espinosa,
Jacqueline Johnson,
Jacquelyn D Hokamp,
Jamie D Swann,
Jamie L Dion,
Jennifer L Barre,
Jesse P Hardin,
Jessica D Nanini,
Jessica D Weber,
Jessica K Yoon,
John Dan,
Johnson,
Joshua C Schafer,
Julie A Silberberg,
Julie M Anbarchian,
Justin A Hefferman,
Justin C Fuller,
Karen A Spencer,
Kristen E Szenderski,
Latoya S Oliver Powell,
Laura B Kennedy,
Laurissa S Flowers,
LCDR Cornelius Brown, III,
Lisa R Heath,
Marc A Jackson, Jr,
Mildred L Mccray,
Mohamad A Chahine,
Monique Rac Lester,
Myra L Gemmill,
Myra L Reed,
Nancy L Meade,
Natasha A Dezinna,
Nicholas P Schaub,
Nina D Patel,
Norman Fogg,
Osama M Hamoud,
Patricia A Maestas,
Pelekakis,
Philip W Beck,
Qin Xu,
Rachael A Wiederock,
Rachel C Harrington,
Renisha M Shaw,
Rina Bhikha,
Shererk,
Shusheen A Alexander,
Susan J Essenmacher,
Tamara L Setzer,
Tamara N Champion,
Tania K Mercado,
Thomas N Adjabeng,
Tiki J Dixon,
Valeria A Moore,
Wayne L Jefferson,
William A Warnick,
William D Murray
Upendra Paudel's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2020 | FDA 483 | Totally Cool, Inc. - Form 483, 2020-01-07 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more